3 original drug prices to fall by 20% in September

Published: 2009-08-21 06:57:00

Updated: 2009-08-21 06:57:00

The insurance prices of three original drugs, such as Boryung’s Astrix, Otsuka’s Obcort and Janssen’s Reminyl will be reduced by 20% from the next month, the Ministry for Health, Welfare and Family Affairs said on August 18.

The ministry said that under the so-called positive list system, when...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK